RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $791M
1-Year Est. Return 12.81%
This Quarter Est. Return
1 Year Est. Return
+12.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$783M
AUM Growth
+$86.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
120
New
Increased
Reduced
Closed

Top Buys

1
+$14.5M
2
+$12.9M
3
+$11.6M
4
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$10.1M
5
GKOS icon
Glaukos
GKOS
+$9.98M

Top Sells

1
+$15M
2
+$13.8M
3
+$11.6M
4
NVCR icon
NovoCure
NVCR
+$10.9M
5
BIIB icon
Biogen
BIIB
+$8.3M

Sector Composition

1 Healthcare 89.3%
2 Financials 1.39%
3 Technology 0.15%
4 Energy 0.13%
5 Consumer Discretionary 0.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
101
– –
-23,280
102
– –
-40,000
103
– –
-35,000
104
– –
-30,000
105
– –
-25,000
106
– –
-23,400
107
– –
-92,700
108
– –
-50,000
109
– –
-1,221
110
– –
-23,920
111
– –
-30,099
112
– –
-277,303
113
– –
-15,000
114
– –
-5,226
115
– –
-213,901
116
– –
-25,000
117
– –
-60,000
118
– –
-120,000
119
– –
-461,654
1 2 3 4
5